These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 1673814

  • 1. [Effect of sulfasalazine and its metabolites on prostaglandin and leukotriene liberation from human synovial tissue].
    Wittenberg HR, Kleemeyer K, Peskar BM, Peskar BA.
    Wien Klin Wochenschr; 1991; 103(2):34-9. PubMed ID: 1673814
    [Abstract] [Full Text] [Related]

  • 2. [Prostaglandin and leukotriene release of synovial tissue in various joint diseases].
    Wittenberg RH, Willburger RE, Kleemeyer KS, Schleberger R.
    Z Orthop Ihre Grenzgeb; 1991; 129(6):531-6. PubMed ID: 1837403
    [Abstract] [Full Text] [Related]

  • 3. Effects of sulfasalazine and its metabolites on steady state messenger RNA concentrations for inflammatory cytokines, matrix metalloproteinases, and tissue inhibitors of metalloproteinase in rheumatoid synovial fibroblasts.
    Minghetti PP, Blackburn WD.
    J Rheumatol; 2000 Mar; 27(3):653-60. PubMed ID: 10743803
    [Abstract] [Full Text] [Related]

  • 4. In vitro release of prostaglandins and leukotrienes from synovial tissue, cartilage, and bone in degenerative joint diseases.
    Wittenberg RH, Willburger RE, Kleemeyer KS, Peskar BA.
    Arthritis Rheum; 1993 Oct; 36(10):1444-50. PubMed ID: 8216404
    [Abstract] [Full Text] [Related]

  • 5. In vitro immunomodulatory effects of sulfasalazine and its metabolites.
    Comer SS, Jasin HE.
    J Rheumatol; 1988 Apr; 15(4):580-6. PubMed ID: 2899646
    [Abstract] [Full Text] [Related]

  • 6. Is the beneficial effect of sulfasalazine due to inhibition of synovial neovascularization?
    Madhok R, Wijelath E, Smith J, Watson J, Sturrock RD, Capell HA.
    J Rheumatol; 1991 Feb; 18(2):199-202. PubMed ID: 1708829
    [Abstract] [Full Text] [Related]

  • 7. Influence of sulfasalazine, 5-aminosalicylic acid and sulfapyridine on prostanoid synthesis and metabolism in rabbit colonic mucosa.
    Kolassa N, Becker R, Wiener H.
    Prostaglandins; 1985 Jan; 29(1):133-42. PubMed ID: 2858116
    [Abstract] [Full Text] [Related]

  • 8. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on reactive oxygen species in comparison with salazosulfapyridine and its metabolite sulfapyridine.
    Kimura I, Kumamoto T, Matsuda A, Kataoka M, Kokuba Y.
    Arzneimittelforschung; 1998 Oct; 48(10):1007-11. PubMed ID: 9825118
    [Abstract] [Full Text] [Related]

  • 9. The effect of sulfasalazine on rheumatoid arthritic synovial tissue chemokine production.
    Volin MV, Campbell PL, Connors MA, Woodruff DC, Koch AE.
    Exp Mol Pathol; 2002 Oct; 73(2):84-92. PubMed ID: 12231210
    [Abstract] [Full Text] [Related]

  • 10. 5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells.
    Stevens C, Lipman M, Fabry S, Moscovitch-Lopatin M, Almawi W, Keresztes S, Peppercorn MA, Strom TB.
    J Pharmacol Exp Ther; 1995 Jan; 272(1):399-406. PubMed ID: 7815356
    [Abstract] [Full Text] [Related]

  • 11. Release of leukotrienes C4 and B4 and prostaglandin E2 from human monocytes stimulated with aggregated IgG, IgA, and IgE.
    Ferreri NR, Howland WC, Spiegelberg HL.
    J Immunol; 1986 Jun 01; 136(11):4188-93. PubMed ID: 3009617
    [Abstract] [Full Text] [Related]

  • 12. Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicyclic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis.
    Volin MV, Harlow LA, Woods JM, Campbell PL, Amin MA, Tokuhira M, Koch AE.
    Arthritis Rheum; 1999 Sep 01; 42(9):1927-35. PubMed ID: 10513809
    [Abstract] [Full Text] [Related]

  • 13. [Inhibition of release of prostaglandins and leukotrienes from calcimycin-induced mouse peritoneal macrophages and bovine aorta endothelial cells by anisodamine].
    Li J, Jiang YY, Yue TL.
    Zhongguo Yao Li Xue Bao; 1989 May 01; 10(3):274-8. PubMed ID: 2558499
    [Abstract] [Full Text] [Related]

  • 14. Enhanced formation of sulfidopeptide-leukotrienes in ulcerative colitis and Crohn's disease: inhibition by sulfasalazine and 5-aminosalicylic acid.
    Peskar BM, Dreyling KW, Peskar BA, May B, Goebell H.
    Agents Actions; 1986 Jun 01; 18(3-4):381-3. PubMed ID: 2875632
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of eicosanoid release from synovial organ culture by incubation with tepoxalin and its acid metabolite.
    Willburger RE, Wittenberg RH, Kleemeyer KS, Hoos R, Brunner-Ferber FL, Peskar BA.
    Prostaglandins; 1996 Oct 01; 52(4):327-38. PubMed ID: 8936587
    [Abstract] [Full Text] [Related]

  • 16. Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis?
    Bird HA.
    Br J Rheumatol; 1995 Nov 01; 34 Suppl 2():16-9. PubMed ID: 8535642
    [Abstract] [Full Text] [Related]

  • 17. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine.
    Kimura I, Kawasaki M, Matsuda A, Kataoka M, Kokurba Y.
    Arzneimittelforschung; 1998 Dec 01; 48(12):1163-7. PubMed ID: 9893931
    [Abstract] [Full Text] [Related]

  • 18. Arachidonic acid metabolism and intracellular calcium concentration in inflammatory bowel disease.
    Schmidt C, Kosché E, Baumeister B, Vetter H.
    Eur J Gastroenterol Hepatol; 1995 Sep 01; 7(9):865-9. PubMed ID: 8574719
    [Abstract] [Full Text] [Related]

  • 19. Sulfasalazine treatment and lymphocyte function in patients with rheumatoid arthritis.
    Symmons DP, Salmon M, Farr M, Bacon PA.
    J Rheumatol; 1988 Apr 01; 15(4):575-9. PubMed ID: 2899645
    [Abstract] [Full Text] [Related]

  • 20. [Leukotriene synthesis by gastrointestinal tissue and its pharmacologic modification].
    Peskar BM, Kozuschek W, Morgenroth K, Hoppe U, Dreyling KW, Peskar BA.
    Wien Klin Wochenschr; 1986 Feb 21; 98(4):98-104. PubMed ID: 3010577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.